Leuprolide Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01790126The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
NCT00582556Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
NCT02059213A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
NCT02057939Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
NCT01547299Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
NCT00223665Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
NCT00283803Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
NCT02083185A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer
NCT01194271Neoadjuvant Ipilimumab in Prostate Cancer
NCT00500110Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
NCT00016913Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
NCT00028769S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00103376Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
NCT00924469A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
NCT01088529Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
NCT01076335Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
NCT00587431Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
NCT00684905Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
NCT00658697Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
NCT00003124Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00002889Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
NCT02107391Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
NCT02212197Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer